Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Ferrer discloses antibacterial agents

Feb. 15, 2016

Cocrystal inlicenses CRISPR/Cas9 technologies

Feb. 11, 2016

Cidara Therapeutics's CD101 IV wins FDA orphan drug status

Feb. 11, 2016

EMA creates Zika virus task force, HemispheRx announces its approach

Feb. 10, 2016

Cellceutix plans SPA request for phase III study of brilacidin in ABSSSI

Feb. 10, 2016

New animal model created for the investigation of glanders

Feb. 10, 2016

Cisen Pharmaceutical and Medshine Discovery reveal compounds to treat tuberculosis

Feb. 10, 2016

Biota starts patient dosing in phase II trial evaluating topical BTA-074 antiviral gel

Feb. 9, 2016

New Ebola virus model developed in rhesus monkeys

Feb. 9, 2016

GlaxoSmithKline's gepotidacin shows potential against anthrax

Feb. 9, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...